Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Would you recommend routinely checking ANCA levels just prior to a planned kidney transplantation in patients with a history of ESKD secondary to ANCA-associated vasculitis?
Related Questions
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
What is your approach to waiting period for an ESKD patient getting a kidney transplant after just being treated for bacteremia?
What is the best way to assess exercise capacity in kidney transplantation candidates to predict post-transplant outcomes?
What is your approach to management of tremors in a kidney transplant recipient who is taking a CNI for immunosuppression?
How do you approach kidney transplant evaluation and management in an ESKD patient with a history of anti-GBM disease and currently detectable anti-GBM antibodies?
How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
How has your approach to managing asymptomatic bacteriuria in kidney transplant patients changed in light of a recent meta-analysis showing no significant differences in pyelonephritis, symptomatic UTI, or graft loss between patients treated with antibiotics and those who were not treated?
What are the best practices for preparing blood for transfusion in a patient with a kidney transplant to minimize complications?
What is your approach to dose adjusting mycophenolate in a kidney transplant recipient who is transitioned from tacrolimus to cyclosporine?
